GNT Pharma: Clinical Trials

1 trial sponsored by GNT Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow GNT Pharma: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz
Neu2000KWL group, Placebo group - Ischemic Stroke
Phase 3UnknownGNT Pharma4962021-12-252022-09-26

Conditions studied

Ischemic Stroke (1)

Countries

South Korea (1)

Top investigators

Sun Uck Kwon, MD, PhD (1)

Results publications

PMID 36746385, PMID 39874036